BIEL, JUST OUT!
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch? Therapy Box
FREDERICK, Md., March 7, 2014 /PRNewswire via COMTEX/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch? Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
While making its commendation in the Most Innovative New OTC Product category the award judges said, "BioElectronics' Smart Insole rides the wave of wearable tech' that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem." Bayer AG was top entrant in the category with 35 points to BioElectronics' 32.
"This industry recognition caps a year of wins for our new Smart Insole(TM) Heel Pain Therapy product -- both in superb customer feedback and successful clinical trial results," said Andrew Whelan, president of BioElectronics Corporation. "Our customers have said that the Smart Insole product is the most successful, easy to use and proven treatment for common heel pain such as plantar fasciitis."
BioElectronics retail box for Boots, designed by its own in-house marketing team was named Runner-up in the "Best New OTC Packaging Design" finishing one point behind the winner, the Bray Lenino, ad agency. Judges said, "The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands."
The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries. A panel of independent experts experienced and knowledgeable in the OTC market judges each award.
AI
